Skip to main content
ACoP 2024 Main banner
Final Program


Conference Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Wilhelmus E. De Witte, PhD

Lead Large Molecule Platform - Principal Scientist
ESQlabs, Belgium

Wilbert de Witte is a Prinicipal Scientist and Large Molecule PBPK Platform lead at ESQlabs.

Before joining esqLABS, he worked at Ablynx NV, later Sanofi Ghent, on the preclinical and clinical development of NANOBODY® therapeutics. He developed several PBPK and PBPK-QSP models as well as traditional TMDD and PKPD models for mechanistic analysis of in vitro, in vivo, and clinical data. He accumulated in-depth knowledge on the behavior of large molecules in different modalities and with various target binding characteristics.

Wilbert de Witte obtained his Master’s degree in Bio-Pharmaceutical Sciences from Leiden University (the Netherlands). For his PhD thesis, he studied the impact of drug-target binding kinetics on in vivo drug action at Leiden University.

Disclosure(s): No financial relationships to disclose

Presentation(s):